Cargando…

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

BACKGROUND: Tumor necrosis factor (TNF)-α inhibitors are increasingly being used in inflammatory bowel disease (IBD). Because this chronic intestinal disorder often affects women of fertile age, it is essential to assess the effect of biologics on pregnancy outcome. METHODS: We performed a systemati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Ole Haagen, Loftus Jr, Edward V, Jess, Tine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734216/ https://www.ncbi.nlm.nih.gov/pubmed/23902720 http://dx.doi.org/10.1186/1741-7015-11-174

Ejemplares similares

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD
por: Soendergaard, Christoffer, et al.
Publicado: (2018)

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD
por: LUPU, A., et al.
Publicado: (2014)

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
por: Ditto, Maria Chiara, et al.
Publicado: (2021)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2021)

The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2018)

Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD
por: Johnson, Amanda M., et al.
Publicado: (2021)

Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials
por: Nielsen, Ole Haagen, et al.
Publicado: (2020)

Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD
por: Coufal, Stepan, et al.
Publicado: (2023)

Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
por: Dudek, Patrycja, et al.
Publicado: (2021)

Modulation of cytokine patterns and microbiome during pregnancy in IBD
por: van der Giessen, Janine, et al.
Publicado: (2020)

TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes
por: Dai, Fang-fang, et al.
Publicado: (2022)

Identification of TNF-α-Responsive Promoters and Enhancers in the Intestinal Epithelial Cell Model Caco-2
por: Boyd, Mette, et al.
Publicado: (2014)

COX-2–PGE(2) Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis
por: Li, Yuan, et al.
Publicado: (2018)

Risk of Adverse Pregnancy Outcomes for Women with IBD in an Expert IBD Antenatal Clinic
por: Lever, Gillian, et al.
Publicado: (2022)

TNF-α inhibitors: are they carcinogenic?
por: Raval, Girindra, et al.
Publicado: (2010)

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors
por: Sikorska, Dorota, et al.
Publicado: (2019)

Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients
por: Dadaei, Tahereh, et al.
Publicado: (2015)

Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases
por: Gray, Marcus A., et al.
Publicado: (2018)

Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors
por: Minnema, Lotte A., et al.
Publicado: (2020)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

New Strategies for Treatment of Inflammatory Bowel Disease
por: Nielsen, Ole Haagen
Publicado: (2014)

Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy
por: Schierova, Dagmar, et al.
Publicado: (2021)

Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients
por: Vicente-Steijn, R., et al.
Publicado: (2020)

Secondary Mania induced by TNF‐α inhibitors: A systematic review
por: Miola, Alessandro, et al.
Publicado: (2021)

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
por: Gaujoux, Renaud, et al.
Publicado: (2019)

IBD metabonomics predicts phenotype, disease course, and treatment response
por: Bjerrum, Jacob T., et al.
Publicado: (2021)

Efficacy and safety of IL inhibitors, TNF-α inhibitors, and JAK inhibitors in patients with ankylosing spondylitis: a systematic review and Bayesian network meta-analysis
por: Tian, Cong, et al.
Publicado: (2023)

Safety of TNF inhibitors in adolescents and children
por: McCluggage, Lauren Keyser
Publicado: (2010)

Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy
por: Esteve-Solé, Ana, et al.
Publicado: (2017)

Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
por: Nielsen, Ole Haagen, et al.
Publicado: (2015)

Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD
por: Yeaman, Fiona, et al.
Publicado: (2023)

Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy
por: Reiss, Zuzana, et al.
Publicado: (2023)

PReS-FINAL-2334: Chronic recurrent multifocal osteomyelitis and tnf-αlfa inhibitors
por: Alberdi-Saugstrup, M, et al.
Publicado: (2013)

A143 SAFETY OF BIOLOGICAL THERAPIES IN ELDERLY IBD: A SYSTEMATIC REVIEW
por: Golovics, P, et al.
Publicado: (2022)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Switching TNFα inhibitors: Patterns and determinants
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
por: Atreya, Raja, et al.
Publicado: (2022)

Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNFα Non-Response IBD Patients
por: Liu, Yifan, et al.
Publicado: (2020)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
por: Jang, Dan-in, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5pg2kr5u2nvq149311l7haf40